Diabetes and atherosclerosis--a lipoprotein perspective.
Atherosclerosis is the most frequent complication of diabetes. It affects all major vascular beds. The metabolic derangements that occur in diabetes may underlie many of the reasons for this. These abnormalities include alterations in the metabolism of lipoproteins, particularly the triglyceride-rich lipoproteins. Studies are currently being conducted to determine whether correcting the dyslipoproteinaemias associated with diabetes will reduce the risk of atherosclerosis in the diabetic population.
Steiner
G
G
Department of Medicine at The University of Toronto and The Toronto Hospital, and The World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes, Canada.
D001161:Arteriosclerosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D005215:Fasting / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D019518:Postprandial Period / Q000502:physiology; D012307:Risk Factors; D013577:Syndrome; D014280:Triglycerides / Q000097:blood / Q000378:metabolism*
D008074:Lipoproteins; D014280:Triglycerides